Pharmacological characterization of linear analogues of vasopressin generated by the systematic substitution of positions 1 and 6 by l-amino acids
- 1 April 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (9) , 1497-1501
- https://doi.org/10.1016/0006-2952(94)90523-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptorEuropean Journal of Biochemistry, 1993
- V1a Vasopressin Receptors: Selective Biotinylated ProbesPublished by Elsevier ,1993
- Design and synthesis of heterofunctional V1a-selective vasopressin receptor ligands with lysine at position 9Journal of Molecular Endocrinology, 1992
- Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressinInternational Journal of Peptide and Protein Research, 1992
- Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic functionBiochemical Journal, 1991
- A selective biotinylated probe for V1a vasopressin receptorsMolecular and Cellular Endocrinology, 1991
- A radioiodinated linear vasopressin antagonist: A ligand with high affinity and specificity for V1a receptorsFEBS Letters, 1991
- Arginine Vasopressin and Corticotropin Releasing Factor: Binding to Ovine Anterior Pituitary Membranes*Endocrinology, 1990
- Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressinInternational Journal of Peptide and Protein Research, 1988
- No requirement of cyclic conformation of antagonists in binding to vasopressin receptorsNature, 1987